251 related articles for article (PubMed ID: 31766000)
1. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis.
Okada K; Kakeda S; Tahara M
Mult Scler Relat Disord; 2020 Feb; 38():101507. PubMed ID: 31766000
[TBL] [Abstract][Full Text] [Related]
2. Olfactory Dysfunction Reflects Disease Progression in Japanese Patients with Multiple Sclerosis.
Okada K; Kakeda S; Tahara M
Intern Med; 2022 Nov; 61(21):3181-3187. PubMed ID: 35400704
[TBL] [Abstract][Full Text] [Related]
3. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
4. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
5. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
6. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
[TBL] [Abstract][Full Text] [Related]
7. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
[TBL] [Abstract][Full Text] [Related]
8. Association of Smell Identification Deficit with Alzheimer's Disease Assessment Scale-Cognitive Subscale, Japanese Version Scores and Brain Atrophy in Patients with Dementia.
Yoshii F; Onaka H; Kohara S; Ryo M; Takahashi W
Eur Neurol; 2019; 81(3-4):145-151. PubMed ID: 31242486
[TBL] [Abstract][Full Text] [Related]
9. Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis.
Arici Duz O; Saatci O; Karakulak EZ; Birday E; Hanoglu L
Eur Neurol; 2021; 84(3):175-182. PubMed ID: 33831865
[TBL] [Abstract][Full Text] [Related]
10. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Dong X; Xu G; Wang J; Yin N; Meng N
Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
[TBL] [Abstract][Full Text] [Related]
11. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
12. Clinicoradiological features in amyotrophic lateral sclerosis patients with olfactory dysfunction.
Masuda M; Watanabe H; Ogura A; Ohdake R; Kato T; Kawabata K; Hara K; Nakamura R; Atsuta N; Epifanio B; Katsuno M; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):260-266. PubMed ID: 33908332
[No Abstract] [Full Text] [Related]
13. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
14. Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies.
Wnuk M; Drabik L; Marona M; Szaleniec J; Bryll A; Karcz P; Kolasinska J; Kolasinska M; Ziekiewicz M; Skladzien J; Popiela T; Slowik A
Ear Nose Throat J; 2022 Dec; 101(10):640-644. PubMed ID: 33236917
[TBL] [Abstract][Full Text] [Related]
15. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
[TBL] [Abstract][Full Text] [Related]
16. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
18. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
[TBL] [Abstract][Full Text] [Related]
19. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
[TBL] [Abstract][Full Text] [Related]
20. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
